Exact Therapeutics AS Appoints Prominent Ultrasound And Healthcare Expert To Its Board Of Directors
Underscores the Company’s ambition to harness the power of ultrasound in precision therapeutics amplification. OSLO/LONDON: 6 DECEMBER, 2021: Exact Therapeutics AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX), a clinical-stage precision health company evaluating Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today is delighted to announce the appointment of Anders Wold to its Board […]